lhw090
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2013 (NCT01846468)
Timeline
Indications
Mechanism of action
MMEL1 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- lhw090
- lhw090
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02678000 | Phase 2 | Mar 10, 2017 | Novartis |
| NCT02515331 | Phase 2 | Nov 4, 2015 | Novartis |
| NCT01846468 | Phase 1 | Mar 1, 2013 | Novartis |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Novartis | For profit | 3 | 3 | 2 | 2013 |
1 organizations
Page 1 / 1